Recital 9, Regulation (EU) 2024/1048

In forcesince 9 Apr 2024

It is appropriate that the inclusion of protein concentrate from Lemna gibba and Lemna minor in the Union list of novel foods contains the information referred to in Article 9(3) of Regulation (EU) 2015/2283. In this regard, in line with the conditions of use of food supplements containing protein concentrate from Lemna gibba and Lemna minor as proposed by the applicant and assessed by the Authority, it is necessary to inform consumers through the use of appropriate labelling that food supplements containing protein concentrate from Lemna gibba and Lemna minor should only be consumed by adults. The Authority in its opinion also noted that intake of the novel food may lead to intake of phylloquinone (vitamin K1) up to 480 μg/day for adults (160 μg/day from food supplements) and may constitute a risk for patients on anticoagulant medication. Therefore, where the final product contains a quantity of vitamin K that is considered significant in accordance with point 2 of Part A of Annex XIII to Regulation (EU) No 1169/2011 of the European Parliament and of the Council [Regulation (EU) No 1169/2011 of the European Parliament and of the Council of 25 October 2011 on the provision of food information to consumers, amending Regulations (EC) No 1924/2006 and (EC) No 1925/2006 of the European Parliament and of the Council, and repealing Commission Directive 87/250/EEC, Council Directive 90/496/EEC, Commission Directive 1999/10/EC, Directive 2000/13/EC of the European Parliament and of the Council, Commission Directives 2002/67/EC and 2008/5/EC and Commission Regulation (EC) No 608/2004 (OJ L 304, 22.11.2011, p. 18, ELI: http://data.europa.eu/eli/reg/2011/1169/2018-01-01).], the nutrition declaration shall indicate the quantity of vitamin K.